dermatology

Sanofi snaps up acne vaccine developer Origimm Bio

https://pharmaphorum.com/news/sanofi-snaps-up-acne-vaccine-developer-origimm-bio/

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group

https://pharmaphorum.com/partner-content/fishawack-health-welcomes-expert-led-dermatology-initiative-fide-to-its-group/

Patient and market insights from leading KOLs and life science leaders

https://pharmaphorum.com/partner-content/patient-and-market-insights-from-leading-kols-and-life-science-leaders/

Dupixent scores a first in rare skin disease prurigo nodularis

https://pharmaphorum.com/news/dupixent-scores-a-first-in-rare-skin-disease-prurigo-nodularis/

Key drug in Sanofi’s $1.45bn Kymab buyout shows promise in eczema

https://pharmaphorum.com/news/key-drug-in-sanofis-1-45bn-kymab-buyout-shows-promise-in-eczema/

Incyte leads JAK push into eczema as FDA clears Opzelura cream

https://pharmaphorum.com/news/incyte-leads-jak-push-into-eczema-as-fda-clears-opzelura-cream/

Taking a de-centralized approach to cure the Hepatitis C epidemic

https://pharmaphorum.com/partner-content/taking-a-de-centralized-approach-to-cure-the-hepatitis-c-epidemic/

IL-17 tailender UCB gets EU OK for bimekizumab in psoriasis

https://pharmaphorum.com/news/il-17-tailender-ucb-gets-eu-ok-for-bimekizumab-in-psoriasis/

Look out Dupixent, Lilly’s lebrikizumab is on the march

https://pharmaphorum.com/news/look-out-dupixent-lillys-lebrikizumab-is-on-the-march/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search